Market Trends of Organ Care Systems (OCS) Industry
Heart Segment Expected to Hold a Significant Market Share
The growth of the studied segment is attributed to the growing incidence of cardiovascular diseases and the increasing incidence of heart transplants among the global population.
For instance, the data published by American Heart Journal in May 2021 mentioned that almost 1.5% to 1.9% of the population suffers from heart failure in the United States and Canada. In Europe, 1% to 2% of the population suffers from the disease. The same source also stated that 12.1 million patients were suffering from heart failure in China, while in people over 25 years old, the incidence of the disease was around 3 million. Such increasing cases of heart failure are leading to the growing demand for heart transplants. This is expected to contribute to the demand for heart care systems, thereby driving the segment's growth. Furthermore, according to the data published by the Elsevier article in August 2022, nearly 1,113 heart transplants and 101 heart-lung transplants were performed at AIIMS, New Delhi, India, till April 2021. Such a high volume of heart transplants is expected to drive the segment's growth.
Also, establishing various heart transplant centers is expected to drive the demand for organ care systems, fueling the market's growth. For instance, in March 2022, the Asian Institute of Medical Sciences (AIMS) launched the Heart and lung transplant center in North India in collaboration with MGM healthcare to provide easy and fast organ transplant services.
The increasing product approvals for the heart are also expected to contribute to the growth of the studied segment. For instance, in April 2022, TransMedics, Inc. received approval from the United States FDA for its Organ Care System (OCS) heart systems for use with organs from donors after brain death.
Thus, the high volume of heart transplants, rising cardiovascular diseases, and increasing product launches are expected to contribute to the growth of the studied segment over the forecast period.
North America Expected to Hold a Significant Market Share
North America is expected to hold a significant market share owing to the rising demand for organ transplantations and increasing organ donation. Additionally, the quick adoption of advanced technologies in the organ's care systems and the presence of key market players are driving factors for the North American market.
For instance, the data published by Organdonor.gov in March 2022 mentioned that nearly 105,800 patients were on the national transplant waiting list. The report also noted that more than 40,000 transplants were performed in 2021. Similarly, the CIHI data published in June 2022 mentioned that 2,782 organ transplants were performed in Canada in 2021. Such a high volume of organ transplant surgeries and increasing demand for organ transplantations are expected to contribute to the region's market growth. The prevalence of organ failure is another contributing factor. The data published by American Kidney Fund in February 2022 mentioned that nearly 810,000 Americans survive kidney failure, and over 240,00 Americans live with kidney transplants.
Likewise, the high number of organ transplant centers in North American centers is also expected to contribute to the growth of the market. For instance, the article published in AASLD in January 2022 mentioned that CENTARA had approved 84 centers in Mexico for liver transplants. Such growth in approved transplant centers is also expected to drive the demand for organ care systems.
Furthermore, the increasing product developments and approvals are also expected to contribute to the market growth in this region. For instance, in October 2021, Paragonix Technologies commercially launched the LIVERgaurd Donor Liver Preservation System in the United States. The LIVERgaurd System provides a highly controlled, state-of-the-art environment for hypothermic liver preservation, coupled with real-time digital monitoring to safeguard a donor's liver throughout the transplant process.
Thus, the high volume of organ transplantations and increasing demand for transplant surgeries, along with the presence of key players and frequent product launches, are expected to contribute to the market growth in this region over the forecast period.
